Univ-Bio Overview
- Year Founded
-
2004
- Status
-
Public
- Employees
-
810
- Stock Symbol
-
301166
- Investments
-
1
- Share Price
-
$4.30
- (As of Friday Closing)
Univ-Bio General Information
Description
Shanghai Universal Biotech Co Ltd is a focused on antibodies and related products. It is a professional and comprehensive antibody suppliers and antibodies experts , and has a one-stop efforts to develop a life sciences service providers.
Contact Information
Website
www.univ-bio.comCorporate Office
- Building 16, Lane 15, Gudan Road
- Pudong New Area
- Shanghai, 200082
- China
Corporate Office
- Building 16, Lane 15, Gudan Road
- Pudong New Area
- Shanghai, 200082
- China
Univ-Bio Stock Performance
As of 13-Nov-2026, Univ-Bio’s stock price is $4.30. Its current market cap is $370M with 86.2M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.30 | $4.50 | $3.53 - $5.55 | $370M | 86.2M | 2.72M | -$0.03 |
Univ-Bio Financials Summary
As of 30-Sep-2026, Univ-Bio has a trailing 12-month revenue of $177M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 305,301 | 187,055 | 149,755 | 271,567 |
| Revenue | 177,463 | 150,696 | 155,775 | 173,265 |
| EBITDA | (4,933) | (1,593) | 2,238 | 6,532 |
| Net Income | (2,248) | (3,191) | 1,414 | 5,699 |
| Total Assets | 342,384 | 329,072 | 316,355 | 337,355 |
| Total Debt | 13,079 | 7,667 | 2,373 | 3,309 |
Univ-Bio Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Univ-Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Univ-Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Univ-Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Univ-Bio Investments (1)
Univ-Bio’s most recent deal was a Later Stage VC with AstraBio (China) for . The deal was made on 31-Aug-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| AstraBio (China) | 31-Aug-2026 | Later Stage VC | Diagnostic Equipment |
Univ-Bio ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Distribution
Subindustry
Rank
Percentile
Univ-Bio FAQs
-
When was Univ-Bio founded?
Univ-Bio was founded in 2004.
-
Where is Univ-Bio headquartered?
Univ-Bio is headquartered in Shanghai, China.
-
What is the size of Univ-Bio?
Univ-Bio has 810 total employees.
-
What industry is Univ-Bio in?
Univ-Bio’s primary industry is Laboratory Services (Healthcare).
-
Is Univ-Bio a private or public company?
Univ-Bio is a Public company.
-
What is Univ-Bio’s stock symbol?
The ticker symbol for Univ-Bio is 301166.
-
What is the current stock price of Univ-Bio?
As of 13-Nov-2026 the stock price of Univ-Bio is $4.30.
-
What is the current market cap of Univ-Bio?
The current market capitalization of Univ-Bio is $370M.
-
What is Univ-Bio’s current revenue?
The trailing twelve month revenue for Univ-Bio is $177M.
-
What is Univ-Bio’s annual earnings per share (EPS)?
Univ-Bio’s EPS for 12 months was -$0.03.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
